Genetics and genomics of ischemic tolerance

Focus on cardiac and cerebral ischemic preconditioning

David Della-Morte, Fiorella Guadagni, Raffaele Palmirotta, Patrizia Ferroni, Gianluca Testa, Francesco Cacciatore, Pasquale Abete, Franco Rengo, Miguel A. Perez-Pinzon, Ralph L. Sacco, Tatjana Rundek

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A subthreshold ischemic insult applied to an organ such as the heart and/or brain may help to reduce damage caused by subsequent ischemic episodes. This phenomenon is known as ischemic tolerance mediated by ischemic preconditioning (IPC) and represents the most powerful endogenous mechanism against ischemic injury. Various molecular pathways have been implicated in IPC, and several compounds have been proposed as activators or mediators of IPC. Recently, it has been established that the protective phenotype in response to ischemia depends on a coordinated response at the genomic, molecular, cellular and tissue levels by introducing the concept of 'genomic reprogramming' following IPC. In this article, we sought to review the genetic expression profiles found in cardiac and cerebral IPC studies, describe the differences between young and aged organs in IPC-mediated protection, and discuss the potential therapeutic application of IPC and pharmacological preconditioning based on the genomic response.

Original languageEnglish
Pages (from-to)1741-1757
Number of pages17
JournalPharmacogenomics
Volume13
Issue number15
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Ischemic Preconditioning
Genomics
Ischemia
Pharmacology
Phenotype
Wounds and Injuries
Brain

Keywords

  • aging
  • genetic expression profiles
  • genetics
  • ischemic preconditioning
  • ischemic tolerance
  • pharmacological preconditioning
  • stroke
  • vascular disease

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Genetics and genomics of ischemic tolerance : Focus on cardiac and cerebral ischemic preconditioning. / Della-Morte, David; Guadagni, Fiorella; Palmirotta, Raffaele; Ferroni, Patrizia; Testa, Gianluca; Cacciatore, Francesco; Abete, Pasquale; Rengo, Franco; Perez-Pinzon, Miguel A.; Sacco, Ralph L.; Rundek, Tatjana.

In: Pharmacogenomics, Vol. 13, No. 15, 11.2012, p. 1741-1757.

Research output: Contribution to journalArticle

Della-Morte, David ; Guadagni, Fiorella ; Palmirotta, Raffaele ; Ferroni, Patrizia ; Testa, Gianluca ; Cacciatore, Francesco ; Abete, Pasquale ; Rengo, Franco ; Perez-Pinzon, Miguel A. ; Sacco, Ralph L. ; Rundek, Tatjana. / Genetics and genomics of ischemic tolerance : Focus on cardiac and cerebral ischemic preconditioning. In: Pharmacogenomics. 2012 ; Vol. 13, No. 15. pp. 1741-1757.
@article{022ca23378644075ae194b405f0f7a07,
title = "Genetics and genomics of ischemic tolerance: Focus on cardiac and cerebral ischemic preconditioning",
abstract = "A subthreshold ischemic insult applied to an organ such as the heart and/or brain may help to reduce damage caused by subsequent ischemic episodes. This phenomenon is known as ischemic tolerance mediated by ischemic preconditioning (IPC) and represents the most powerful endogenous mechanism against ischemic injury. Various molecular pathways have been implicated in IPC, and several compounds have been proposed as activators or mediators of IPC. Recently, it has been established that the protective phenotype in response to ischemia depends on a coordinated response at the genomic, molecular, cellular and tissue levels by introducing the concept of 'genomic reprogramming' following IPC. In this article, we sought to review the genetic expression profiles found in cardiac and cerebral IPC studies, describe the differences between young and aged organs in IPC-mediated protection, and discuss the potential therapeutic application of IPC and pharmacological preconditioning based on the genomic response.",
keywords = "aging, genetic expression profiles, genetics, ischemic preconditioning, ischemic tolerance, pharmacological preconditioning, stroke, vascular disease",
author = "David Della-Morte and Fiorella Guadagni and Raffaele Palmirotta and Patrizia Ferroni and Gianluca Testa and Francesco Cacciatore and Pasquale Abete and Franco Rengo and Perez-Pinzon, {Miguel A.} and Sacco, {Ralph L.} and Tatjana Rundek",
year = "2012",
month = "11",
doi = "10.2217/pgs.12.157",
language = "English",
volume = "13",
pages = "1741--1757",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "15",

}

TY - JOUR

T1 - Genetics and genomics of ischemic tolerance

T2 - Focus on cardiac and cerebral ischemic preconditioning

AU - Della-Morte, David

AU - Guadagni, Fiorella

AU - Palmirotta, Raffaele

AU - Ferroni, Patrizia

AU - Testa, Gianluca

AU - Cacciatore, Francesco

AU - Abete, Pasquale

AU - Rengo, Franco

AU - Perez-Pinzon, Miguel A.

AU - Sacco, Ralph L.

AU - Rundek, Tatjana

PY - 2012/11

Y1 - 2012/11

N2 - A subthreshold ischemic insult applied to an organ such as the heart and/or brain may help to reduce damage caused by subsequent ischemic episodes. This phenomenon is known as ischemic tolerance mediated by ischemic preconditioning (IPC) and represents the most powerful endogenous mechanism against ischemic injury. Various molecular pathways have been implicated in IPC, and several compounds have been proposed as activators or mediators of IPC. Recently, it has been established that the protective phenotype in response to ischemia depends on a coordinated response at the genomic, molecular, cellular and tissue levels by introducing the concept of 'genomic reprogramming' following IPC. In this article, we sought to review the genetic expression profiles found in cardiac and cerebral IPC studies, describe the differences between young and aged organs in IPC-mediated protection, and discuss the potential therapeutic application of IPC and pharmacological preconditioning based on the genomic response.

AB - A subthreshold ischemic insult applied to an organ such as the heart and/or brain may help to reduce damage caused by subsequent ischemic episodes. This phenomenon is known as ischemic tolerance mediated by ischemic preconditioning (IPC) and represents the most powerful endogenous mechanism against ischemic injury. Various molecular pathways have been implicated in IPC, and several compounds have been proposed as activators or mediators of IPC. Recently, it has been established that the protective phenotype in response to ischemia depends on a coordinated response at the genomic, molecular, cellular and tissue levels by introducing the concept of 'genomic reprogramming' following IPC. In this article, we sought to review the genetic expression profiles found in cardiac and cerebral IPC studies, describe the differences between young and aged organs in IPC-mediated protection, and discuss the potential therapeutic application of IPC and pharmacological preconditioning based on the genomic response.

KW - aging

KW - genetic expression profiles

KW - genetics

KW - ischemic preconditioning

KW - ischemic tolerance

KW - pharmacological preconditioning

KW - stroke

KW - vascular disease

UR - http://www.scopus.com/inward/record.url?scp=84870021478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870021478&partnerID=8YFLogxK

U2 - 10.2217/pgs.12.157

DO - 10.2217/pgs.12.157

M3 - Article

VL - 13

SP - 1741

EP - 1757

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 15

ER -